Shaun Noorian said: Personalized medicine isnt the future
Endocrine (2020) 68(3):51825
GLP-1 receptor agonists are typically initiated when lifestyle modifications and first-line oral antidiabetic agents (such as metformin) have not achieved adequate glycaemic control
Efficacy and Safety of Retatrutide, a Novel GLP-1, GIP, and Glucagon Receptor Agonist for Obesity Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Abdrabou Abouelmagd A
The biotech firm Metsera, which is developing a once-monthly GLP-1 injection, became the object of a bidding war between Pfizer and Novo Nordisk, with Pfizer emerging as the winner
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily licensed for the management of type 2 diabetes mellitus and, in specific cases, for weight management